Evidence map›Paper›PMID 29934305›Full record

ArticleThe Journal of biological chemistry2018

c-Myc is a novel

Lucie Colineau, Ulrike Lambertz, Oriol Fornes, Wyeth W Wasserman, Neil E Reiner

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. c-Myc inhibits macrophage antimycobacterial response inbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Non-Vesicular Lipid Transport Machinery inInternational journal of molecular sciences · 2023
    Review
  12. Frontiers in immunology · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucie ColineauDivision of Infectious Diseases, Department of Medicine, Vancouver Coastal Health Research Institute, Vancouver, British Columbia V5Z 1M9.
Ulrike LambertzDivision of Infectious Diseases, Department of Medicine, Vancouver Coastal Health Research Institute, Vancouver, British Columbia V5Z 1M9.
Oriol FornesCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 3J5, Canada.
Wyeth W WassermanCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 3J5, Canada.
Neil E ReinerDivision of Infectious Diseases, Department of Medicine, Vancouver Coastal Health Research Institute, Vancouver, British Columbia V5Z 1M9. Electronic address: nreiner@mail.ubc.ca.
Vancouver Coastal Health · CAUniversity of British Columbia · CA

Funding

CIHR MOP-125879
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leishmania donovaniHumansLeishmaniasis, VisceralMacrophagesMicroRNAsProto-Oncogene Proteins c-mycVirulence FactorsMicroRNAsMYC protein, humanProto-Oncogene Proteins c-mycVirulence FactorsinfectionLeishmaniamacrophagemicroRNA biogenesismicroRNA (miRNA)Myc (c-Myc)protozoantranscription regulationvirulence factor

Identifiers

PMID29934305
PMCPMC6102154
OpenAlexW2809382066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.